|
Atomistry » Zinc » PDB 4nuo-4o6s » 4nwk | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Atomistry » Zinc » PDB 4nuo-4o6s » 4nwk » |
Zinc in PDB 4nwk: Crystal Structure of Hepatis C Virus Protease (NS3) Complexed with Bms-605339 Aka N-(Tert-Butoxycarbonyl)-3-Me Thyl-L-Valyl-(4R)-N-((1R, 2S)-1-((Cyclopropylsulfonyl)Carba Moyl)-2-Vinylcyclopropyl)-4-((6- Methoxy-1-Isoquinolinyl)Ox Y)-L-ProlinamideProtein crystallography data
The structure of Crystal Structure of Hepatis C Virus Protease (NS3) Complexed with Bms-605339 Aka N-(Tert-Butoxycarbonyl)-3-Me Thyl-L-Valyl-(4R)-N-((1R, 2S)-1-((Cyclopropylsulfonyl)Carba Moyl)-2-Vinylcyclopropyl)-4-((6- Methoxy-1-Isoquinolinyl)Ox Y)-L-Prolinamide, PDB code: 4nwk
was solved by
J.K.Muckelbauer,
H.E.Klei,
with X-Ray Crystallography technique. A brief refinement statistics is given in the table below:
Zinc Binding Sites:
The binding sites of Zinc atom in the Crystal Structure of Hepatis C Virus Protease (NS3) Complexed with Bms-605339 Aka N-(Tert-Butoxycarbonyl)-3-Me Thyl-L-Valyl-(4R)-N-((1R, 2S)-1-((Cyclopropylsulfonyl)Carba Moyl)-2-Vinylcyclopropyl)-4-((6- Methoxy-1-Isoquinolinyl)Ox Y)-L-Prolinamide
(pdb code 4nwk). This binding sites where shown within
5.0 Angstroms radius around Zinc atom.
In total only one binding site of Zinc was determined in the Crystal Structure of Hepatis C Virus Protease (NS3) Complexed with Bms-605339 Aka N-(Tert-Butoxycarbonyl)-3-Me Thyl-L-Valyl-(4R)-N-((1R, 2S)-1-((Cyclopropylsulfonyl)Carba Moyl)-2-Vinylcyclopropyl)-4-((6- Methoxy-1-Isoquinolinyl)Ox Y)-L-Prolinamide, PDB code: 4nwk: Zinc binding site 1 out of 1 in 4nwkGo back to![]() ![]()
Zinc binding site 1 out
of 1 in the Crystal Structure of Hepatis C Virus Protease (NS3) Complexed with Bms-605339 Aka N-(Tert-Butoxycarbonyl)-3-Me Thyl-L-Valyl-(4R)-N-((1R, 2S)-1-((Cyclopropylsulfonyl)Carba Moyl)-2-Vinylcyclopropyl)-4-((6- Methoxy-1-Isoquinolinyl)Ox Y)-L-Prolinamide
![]() Mono view ![]() Stereo pair view
Reference:
P.M.Scola,
A.X.Wang,
A.C.Good,
L.Q.Sun,
K.D.Combrink,
J.A.Campbell,
J.Chen,
Y.Tu,
N.Sin,
B.L.Venables,
S.Y.Sit,
Y.Chen,
A.Cocuzza,
D.M.Bilder,
S.D'andrea,
B.Zheng,
P.Hewawasam,
M.Ding,
J.Thuring,
J.Li,
D.Hernandez,
F.Yu,
P.Falk,
G.Zhai,
A.K.Sheaffer,
C.Chen,
M.S.Lee,
D.Barry,
J.O.Knipe,
W.Li,
Y.H.Han,
S.Jenkins,
C.Gesenberg,
Q.Gao,
M.W.Sinz,
K.S.Santone,
T.Zvyaga,
R.Rajamani,
H.E.Klei,
R.J.Colonno,
D.M.Grasela,
E.Hughes,
C.Chien,
S.Adams,
P.C.Levesque,
D.Li,
J.Zhu,
N.A.Meanwell,
F.Mcphee.
Discovery and Early Clinical Evaluation of Bms-605339, A Potent and Orally Efficacious Tripeptidic Acylsulfonamide NS3 Protease Inhibitor For the Treatment of Hepatitis C Virus Infection. J.Med.Chem. V. 57 1708 2014.
Page generated: Sun Oct 27 03:23:40 2024
ISSN: ISSN 0022-2623 PubMed: 24555570 DOI: 10.1021/JM401840S |
Last articlesNa in 2QB4Na in 2QD6 Na in 2QCI Na in 2QA0 Na in 2Q95 Na in 2Q96 Na in 2Q94 Na in 2Q93 Na in 2Q8X Na in 2Q72 |
© Copyright 2008-2020 by atomistry.com | ||
Home | Site Map | Copyright | Contact us | Privacy |